quinoxalines has been researched along with Drug Abuse, Intravenous in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Barclay, ST; Bradley-Stewart, A; Davis, C; Filipe, A; Fox, R; Gunson, R; MacLean, A; Ngan Chiu Bong, M; Peters, ES; Shah, R; Shepherd, SJ; Thomson, EC; Tong, L; van Vliet, VJE | 1 |
| Gschwantler, M; Gutic, E; Haltmayer, H; Lang, T; Luhn, J; Pirker, R; Reiberger, T; Schmidbauer, C; Schubert, R; Schütz, A; Schwanke, C | 1 |
| Alami, NN; Conway, B; Dillon, JF; Dore, GJ; Dumas, EO; Felizarta, F; Fredrick, LM; Grebely, J; Gschwantler, M; Hézode, C; Mensa, FJ; Tomasiewicz, K | 1 |
| Aglitti, A; Brancaccio, G; Caroleo, B; Claar, E; Coppola, C; Coppola, N; Cozzolongo, R; Di Costanzo, GG; Federico, A; Fontanella, L; Gatti, P; Gentile, I; Longo, A; Masarone, M; Messina, V; Milella, M; Morisco, F; Persico, M; Pierri, P; Rosato, V; Serviddio, G; Sogari, F; Surace, LA; Termite, AP; Terrenato, I; Tundo, P | 1 |
| Warparkowski, A | 1 |
| Altice, F; Barr, E; Chen, E; Conway, B; Dalgard, O; Dore, GJ; Dutko, FJ; Gane, EJ; Gendrano, IN; Grebely, J; Howe, AY; Huang, HC; Litwin, AH; Luetkemeyer, A; Nahass, R; Nguyen, BY; Nickle, DC; Peng, CY; Platt, HL; Robertson, MN; Shibolet, O; Wahl, J | 1 |
1 review(s) available for quinoxalines and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Safety and efficacy of glecaprevir/pibrentasvir in patients with chronic hepatitis C genotypes 1-6 receiving opioid substitution therapy.
Topics: Adult; Antiviral Agents; Benzimidazoles; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Drug Combinations; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Male; Middle Aged; Opiate Substitution Treatment; Pyrrolidines; Quinoxalines; Substance Abuse, Intravenous; Sulfonamides | 2019 |
2 trial(s) available for quinoxalines and Drug Abuse, Intravenous
| Article | Year |
|---|---|
[High chance of healing for opiate dependent patients].
Topics: Amides; Benzofurans; Carbamates; Cyclopropanes; Double-Blind Method; Drug Combinations; Hepatitis C, Chronic; Humans; Imidazoles; Medication Adherence; Opiate Substitution Treatment; Opioid-Related Disorders; Quinoxalines; Substance Abuse, Intravenous; Sulfonamides | 2016 |
Elbasvir-Grazoprevir to Treat Hepatitis C Virus Infection in Persons Receiving Opioid Agonist Therapy: A Randomized Trial.
Topics: Adolescent; Adult; Aged; Antiviral Agents; Benzofurans; Buprenorphine; Buprenorphine, Naloxone Drug Combination; Double-Blind Method; Drug Combinations; Drug Resistance, Viral; Female; Genotype; Hepatitis C, Chronic; Humans; Imidazoles; Male; Medication Adherence; Methadone; Middle Aged; Opiate Substitution Treatment; Opioid-Related Disorders; Quinoxalines; Recurrence; Substance Abuse, Intravenous; Young Adult | 2016 |
3 other study(ies) available for quinoxalines and Drug Abuse, Intravenous
| Article | Year |
|---|---|
Characterisation of a Hepatitis C Virus Subtype 2a Cluster in Scottish PWID with a Suboptimal Response to Glecaprevir/Pibrentasvir Treatment.
Topics: Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Combinations; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Lactams, Macrocyclic; Leucine; Phylogeny; Proline; Pyrrolidines; Quinoxalines; Scotland; Substance Abuse, Intravenous; Sulfonamides | 2022 |
Directly observed therapy for HCV with glecaprevir/pibrentasvir alongside opioid substitution in people who inject drugs-First real world data from Austria.
Topics: Adult; Aged; Austria; Benzimidazoles; Directly Observed Therapy; Drug Combinations; Female; Hepatitis C, Chronic; Humans; Male; Medication Adherence; Middle Aged; Opiate Substitution Treatment; Patient Compliance; Pyrrolidines; Quinoxalines; Social Class; Substance Abuse, Intravenous; Sulfonamides; Sustained Virologic Response; Treatment Outcome; Young Adult | 2020 |
Real-life glecaprevir/pibrentasvir in a large cohort of patients with hepatitis C virus infection: The MISTRAL study.
Topics: Adult; Aged; Aged, 80 and over; Aminoisobutyric Acids; Antiviral Agents; Benzimidazoles; Cyclopropanes; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Italy; Lactams, Macrocyclic; Leucine; Liver Cirrhosis; Longitudinal Studies; Male; Middle Aged; Proline; Prospective Studies; Pyrrolidines; Quinoxalines; Substance Abuse, Intravenous; Sulfonamides; Sustained Virologic Response; Young Adult | 2019 |